NCT06644508

Brief Summary

The goal of this clinical trial is to evaluate and prevent fluid overload in critically ill, mechanically ventilated children. The main questions it aims to answer are:

  1. 1.What is the effect of a restrictive fluid strategy on cumulative fluid balance on day three of invasive mechanical ventilation?
  2. 2.What is the feasibility (e.g. adherence to target intake, fluid balance and nutritional goals) of maintaining a neutral fluid balance?

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
90

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Oct 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

3 active sites

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2024

Completed
9 days until next milestone

First Submitted

Initial submission to the registry

October 10, 2024

Completed
6 days until next milestone

First Posted

Study publicly available on registry

October 16, 2024

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2025

Completed
Last Updated

October 16, 2024

Status Verified

September 1, 2024

Enrollment Period

7 months

First QC Date

October 10, 2024

Last Update Submit

October 14, 2024

Conditions

Keywords

Respiratory InsufficiencyMechanical ventilationFluidsFluid BalanceEdemaFluid OverloadLenght of mechanical ventilationChilderenMaintenance fluids

Outcome Measures

Primary Outcomes (1)

  • Cumulative fluid balance on day 3 in ml/kg

    Cumulative fluid balance (CFB) over the course of three days after the start of mechanical ventilation is noted in ml/kg. CFB is calculated as a sum of daily (fluid intake \[liters\] - total output \[liters\])/ body weight (kilograms).

    From start mechanical ventilation to 72 hours after start of mechanical ventilation

Secondary Outcomes (28)

  • Daily cumulative fluid balance on in ml/kg

    For 10 days, CFB is noted every day at 00:00

  • Protein intake in gr/kg/day

    For ten days after start of mechanical ventilation

  • Bodyweight in grams

    Bodyweight in grams will be measured at start of mechanical ventilation and at 72 hours after start of mechanical ventilation

  • Daily cumulative diuretics dose in mg/kg

    From start of mechnical ventilation for ten days, cumulative diuretic dose will be noted at 00:00

  • Blood urea nitrogen (BUN) in mmol/L

    BUN will be measured at 24 hours, 72 hours and at 120 hours after start of mechanical ventilation

  • +23 more secondary outcomes

Study Arms (2)

Observation of current local practices

NO INTERVENTION

Current local practices regarding fluid management will be observed. Population: Critically ill children receiving mechanical ventilation due to respiratory insufficiency. Patients will be treated according to local protocols at the discretion of the attending physicians.

Strict adherence to european guidelines

ACTIVE COMPARATOR

In this intervention attending physicians will be encouraged to strictly adhere the European (ESPNIC) guidelines regarding fluid management.

Other: Strict adherence to European guidelines

Interventions

The goal is to maintain a neutral fluid balance throughout the course of intubation if clinical practice allows. Therefore: * From the start of mechanical ventilation, the maximum maintenance fluids is 65% of the maintenance fluids proposed by the Holliday \& Segar formula. Fluid resuscitation in the first hours after intubation is at the discretion of the attending physician. * Any other interventions to maintain a neutral fluid balance (e.g., starting diuretics, reducing fluid boluses, decreasing creep fluids, or using more concentrated enteral feeding) are at the discretion of the attending physician. * Throughout the intervention, the attending physician decides if clinical practice allows for a decrease in fluid balance, and international feeding goals must always be met.

Strict adherence to european guidelines

Eligibility Criteria

AgeUp to 10 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Age \< 10 years and weight \< 35 kg
  • Receiving invasive mechanical ventilation (IMV) due to respiratory failure
  • Expected duration of IMV \> 48 hours

You may not qualify if:

  • Preterm (\<37weeks gestational age)
  • Preexistent (clinical) diagnosis of kidney disease
  • Congenital cardiac defect with hemodynamic consequences or reduced cardiac function
  • (Ongoing) shock with need for fluid resuscitation and/or vasoactive drugs
  • Cardiovascular (including diuretics) drug use on admission (home medication)
  • Pre-existent (clinical) diagnosis of liver failure
  • Right of left heart failure
  • Pulmonary hypertension
  • ECMO treatment
  • Receiving total parenteral nutrition on admission which won't be stopped
  • Failure to include within 12 hours after start of IMV
  • Expected duration of IMV \< 48 hours
  • Parents or caretakers unable to understand/speak Dutch language
  • Surgery \< 48 hours

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Radboudumc

Nijmegen, Gelderland, 6525 GA, Netherlands

Location

Amsterdam MC

Amsterdam, North Holland, 1100 DD, Netherlands

Location

ErasmusMC

Rotterdam, South Holland, 3015 CN, Netherlands

Location

Related Publications (6)

  • Arrahmani I, Ingelse SA, van Woensel JBM, Bem RA, Lemson J. Current Practice of Fluid Maintenance and Replacement Therapy in Mechanically Ventilated Critically Ill Children: A European Survey. Front Pediatr. 2022 Feb 23;10:828637. doi: 10.3389/fped.2022.828637. eCollection 2022.

    PMID: 35281243BACKGROUND
  • Valentine SL, Sapru A, Higgerson RA, Spinella PC, Flori HR, Graham DA, Brett M, Convery M, Christie LM, Karamessinis L, Randolph AG; Pediatric Acute Lung Injury and Sepsis Investigator's (PALISI) Network; Acute Respiratory Distress Syndrome Clinical Research Network (ARDSNet). Fluid balance in critically ill children with acute lung injury. Crit Care Med. 2012 Oct;40(10):2883-9. doi: 10.1097/CCM.0b013e31825bc54d.

    PMID: 22824936BACKGROUND
  • Ingelse SA, Geukers VG, Dijsselhof ME, Lemson J, Bem RA, van Woensel JB. Less Is More?-A Feasibility Study of Fluid Strategy in Critically Ill Children With Acute Respiratory Tract Infection. Front Pediatr. 2019 Dec 10;7:496. doi: 10.3389/fped.2019.00496. eCollection 2019.

    PMID: 31921715BACKGROUND
  • Diaz F, Nunez MJ, Pino P, Erranz B, Cruces P. Implementation of preemptive fluid strategy as a bundle to prevent fluid overload in children with acute respiratory distress syndrome and sepsis. BMC Pediatr. 2018 Jun 26;18(1):207. doi: 10.1186/s12887-018-1188-6.

    PMID: 29945586BACKGROUND
  • Charaya S, Angurana SK, Nallasamy K, Jayashree M. Restricted versus Usual/Liberal Maintenance Fluid Strategy in Mechanically Ventilated Children: An Open-Label Randomized Trial (ReLiSCh Trial). Indian J Pediatr. 2025 Jan;92(1):7-14. doi: 10.1007/s12098-023-04867-4. Epub 2023 Oct 18.

    PMID: 37851328BACKGROUND
  • Brossier DW, Tume LN, Briant AR, Jotterand Chaparro C, Moullet C, Rooze S, Verbruggen SCAT, Marino LV, Alsohime F, Beldjilali S, Chiusolo F, Costa L, Didier C, Ilia S, Joram NL, Kneyber MCJ, Kuhlwein E, Lopez J, Lopez-Herce J, Mayberry HF, Mehmeti F, Mierzewska-Schmidt M, Minambres Rodriguez M, Morice C, Pappachan JV, Porcheret F, Reis Boto L, Schlapbach LJ, Tekguc H, Tziouvas K, Parienti JJ, Goyer I, Valla FV; Metabolism Endocrinology and Nutrition section of the European Society of Pediatric and Neonatal Intensive Care (ESPNIC). ESPNIC clinical practice guidelines: intravenous maintenance fluid therapy in acute and critically ill children- a systematic review and meta-analysis. Intensive Care Med. 2022 Dec;48(12):1691-1708. doi: 10.1007/s00134-022-06882-z. Epub 2022 Oct 26.

    PMID: 36289081BACKGROUND

MeSH Terms

Conditions

EdemaRespiratory Insufficiency

Condition Hierarchy (Ancestors)

Signs and SymptomsPathological Conditions, Signs and SymptomsRespiration DisordersRespiratory Tract Diseases

Study Officials

  • Joris Lemson, MD PhD

    Radboud University Medical Center

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Joris Lemson, MD PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
SEQUENTIAL
Model Details: Multicentre prospective study (clinical implementation evaluation) with a before-after design with continuous recruitment and single measurements
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 10, 2024

First Posted

October 16, 2024

Study Start

October 1, 2024

Primary Completion

May 1, 2025

Study Completion

May 1, 2025

Last Updated

October 16, 2024

Record last verified: 2024-09

Data Sharing

IPD Sharing
Will share

* Demograpghics data * Outcome data

Shared Documents
STUDY PROTOCOL
Time Frame
From publication until 15 years after publication
Access Criteria
Data will be made available upon reasonable request to the corresponding author

Locations